MiMedx Announces $10 Million Stock Repurchase Program

[PR Newswire] – MARIETTA, Ga., May 12, 2014 /PRNewswire/ — MiMedx Group, Inc. (MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced toda more

View todays social media effects on MDXG

View the latest stocks trending across Twitter. Click to view dashboard

See who MiMedx is hiring next, click here to view